People

Heidi B. Treiber

Attorney

Treiber, Heidi (new)
Heidi Treiber practices corporate and securities law, with emphases in the areas of public and private offerings, SEC compliance and public company representation. Ms. Treiber counsels public companies on ongoing corporate legal matters, including federal securities reporting requirements and corporate governance issues. She also provides ongoing and transactional advice to private companies. She has experience representing clients with initial and continued listings on the NASDAQ Stock Market, the New York Stock Exchange and NYSE MKT. In addition, she has experience with applications for confidential treatment filed with the SEC, blue sky compliance for private offerings and underwriter representation for public offerings, including FINRA filings.

Publications & News

View

November 6, 2017

WilmerHale Represents 1366 Technologies in $9M Series D Funding

Developer of manufacturing solutions for silicon cell manufacturers, 1366 Technologies, has raised $9 million in Series D funding from strategic partners and return investors.

July 27, 2017

WilmerHale Represents Kala Pharmaceuticals in $103.5 Million IPO

On July 25, 2017, Kala Pharmaceuticals, Inc. announced the closing of its initial public offering of 6,900,000 shares of common stock, including the underwriters' exercise in full of their option to purchase an additional 900,000 shares, at the public offering price of $15.00 per share.

December 23, 2016

WilmerHale Reps Editas Medicine in Licensing of New Technologies

Editas Medicine, Inc., a leading genome editing company, announced it has exclusively licensed intellectual property related to new CRISPR technologies for human therapeutics that will enhance and broaden the range of medicines the company can develop.

October 6, 2016

WilmerHale Advises Catabasis Pharmaceuticals in Closing of $11.5M Offering of Common Stock

The WilmerHale deal team was led by Partner Rosemary Reilly and included Counsel Jeffries Oliver-Li, Associate Timothy Kulis, and Attorney Heidi Treiber.

August 18, 2016

WilmerHale Advises Franklin Street Properties in $83M Closing of Common Stock Offering

Franklin Street Properties Corp. closed an underwritten public offering of its common stock on August 16, 2016.

July 28, 2016

WilmerHale Advises Argos Therapeutics in Pricing of $50M Public Offering

Argos Therapeutics, Inc., an immuno-oncology company focused on the development and commercialization of individualized immunotherapies for the treatment of cancer based on the Arcelis® technology platform, announced the pricing of its public offering of $50 million.

July 20, 2016

WilmerHale Advises PerkinElmer in €500M Eurobond Offering

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced that it has completed a public offering of €500 million aggregate principal amount of 1.875% Senior Notes due 2026 at an issue price of 99.118% of the principal amount.

June 22, 2016

WilmerHale Counsels Zaius in $8M Series B Funding Led by Underscore.VC

Zaius, the only CRM built for the scale and velocity of business-to-consumer marketers, announced it has closed an $8 million investment led by _Underscore.VC, with participation from Leaders Fund and existing investor Matrix Partners.

May 26, 2011

WilmerHale Advises Yandex in $1.4 Billion NASDAQ IPO

Practices

Skip Navigation Links.

Education

JD, magna cum laude, Suffolk University Law School, 1998, Moot Court Board

BA, Colgate University, 1994

Bar Admissions

Massachusetts

Skip Navigation Links.